ONS - Oncobiologics, Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
1.17
-0.02 (-1.68%)
At close: 2:09PM EST
Stock chart is not supported by your current browser
Previous Close1.19
Open1.17
Bid0.00 x 0
Ask1.24 x 3000
Day's Range1.17 - 1.18
52 Week Range0.78 - 3.52
Volume8,761
Avg. Volume95,611
Market Cap30.116M
BetaN/A
PE Ratio (TTM)N/A
EPS (TTM)-1.71
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est1.50
Trade prices are not sourced from all markets
  • Want To Invest In Oncobiologics Inc (NASDAQ:ONS)? Here’s How It Performed Lately
    Simply Wall St.2 days ago

    Want To Invest In Oncobiologics Inc (NASDAQ:ONS)? Here’s How It Performed Lately

    For investors, increase in profitability and industry-beating performance can be essential considerations in an investment. Below, I will examine Oncobiologics Inc’s (NASDAQ:ONS) track record on a high level, to giveRead More...

  • GlobeNewswire7 days ago

    Oncobiologics Reports First Quarter Fiscal Year 2018 Results

    CRANBURY, N.J., Feb. 14, 2018-- Oncobiologics, Inc. today reported financial results and business highlights for its first fiscal quarter ended December 31, 2017. Oncobiologics had a net loss attributable ...

  • GlobeNewswire7 days ago

    Oncobiologics Receives Positive Nasdaq Listing Determination

    CRANBURY, N.J., Feb. 13, 2018-- Oncobiologics, Inc. announced today that on February 13, 2018, the Company received formal notice that the Nasdaq Hearings Panel has granted the Company’ s request for the ...

  • What You Must Know About Oncobiologics Inc’s (NASDAQ:ONS) Major Investors
    Simply Wall St.7 days ago

    What You Must Know About Oncobiologics Inc’s (NASDAQ:ONS) Major Investors

    In this article, I will take a quick look at Oncobiologics Inc’s (NASDAQ:ONS) recent ownership structure – an unconventional investing subject, but an important one. When it comes to ownershipRead More...

  • GlobeNewswire12 days ago

    Oncobiologics Announces Term Extension of Series A Warrants

    CRANBURY, N.J., Feb. 09, 2018-- Oncobiologics, Inc. announced today an extension to the term for exercise of its publicly traded Series A warrants.. The Series A warrants were issued as part of the units ...

  • Is Oncobiologics Inc’s (NASDAQ:ONS) CEO Paid Enough To Stay Motivated?
    Simply Wall St.2 months ago

    Is Oncobiologics Inc’s (NASDAQ:ONS) CEO Paid Enough To Stay Motivated?

    Pankaj Mohan took the helm as Oncobiologics Inc’s (NASDAQ:ONS) CEO and grew market cap to USD$29.68M recently. Recognizing whether CEO incentives are aligned with shareholders is a crucial part ofRead More...

  • Does Oncobiologics Inc’s (ONS) Recent Track Record Look Strong?
    Simply Wall St.3 months ago

    Does Oncobiologics Inc’s (ONS) Recent Track Record Look Strong?

    For investors with a long-term horizon, assessing earnings trend over time and against industry benchmarks is more valuable than looking at a single earnings announcement in one point in time.Read More...

  • Is Oncobiologics Inc (ONS) Thriving Or Barely Surviving In The Healthcare Sector?
    Simply Wall St.3 months ago

    Is Oncobiologics Inc (ONS) Thriving Or Barely Surviving In The Healthcare Sector?

    Oncobiologics Inc (NASDAQ:ONS), a USD$34.16M small-cap, is a healthcare company operating in an industry, which faces key trends such as rising demand fuelled by an aging population and the growingRead More...

  • Breaking Down Oncobiologics Inc’s (ONS) Ownership Structure
    Simply Wall St.4 months ago

    Breaking Down Oncobiologics Inc’s (ONS) Ownership Structure

    In this analysis, my focus will be on developing a perspective on Oncobiologics Inc’s (NASDAQ:ONS) latest ownership structure, a less discussed, but important factor. A company’s ownership structure is oftenRead More...

  • Capital Cube4 months ago

    ETFs with exposure to Oncobiologics, Inc. : October 11, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Oncobiologics, Inc. Here are 5 ETFs with the largest exposure to ONS-US. Comparing the performance and risk of Oncobiologics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • ACCESSWIRE5 months ago

    Featured Company News - Oncobiologics Announces Partnership with GMS Tenshi Holdings; Set to Accelerate the Commercialization of Biosimilar Candidates

    Research Desk Line-up: BiondVax Pharma Post Earnings Coverage LONDON, UK / ACCESSWIRE / September 12, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for ...

  • Capital Cube6 months ago

    ETFs with exposure to Oncobiologics, Inc. : August 25, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Oncobiologics, Inc. Here are 5 ETFs with the largest exposure to ONS-US. Comparing the performance and risk of Oncobiologics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Oncobiologics, Inc. :ONS-US: Earnings Analysis: Q3, 2017 By the Numbers : August 16, 2017
    Capital Cube6 months ago

    Oncobiologics, Inc. :ONS-US: Earnings Analysis: Q3, 2017 By the Numbers : August 16, 2017

    Categories: Yahoo FinanceGet free summary analysis Oncobiologics, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Oncobiologics, Inc. – Momenta Pharmaceuticals, Inc. and Seres Therapeutics Inc (MNTA-US and MCRB-US) that have also reported for this period. Highlights Summary numbers: Revenues of USD 0.30 million, Net ... Read more (Read more...)

  • Capital Cube8 months ago

    ETFs with exposure to Oncobiologics, Inc. : July 4, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Oncobiologics, Inc. Here are 5 ETFs with the largest exposure to ONS-US. Comparing the performance and risk of Oncobiologics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Capital Cube10 months ago

    ETFs with exposure to Oncobiologics, Inc. : April 7, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Oncobiologics, Inc. Here are 5 ETFs with the largest exposure to ONS-US. Comparing the performance and risk of Oncobiologics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Oncobiologics, Inc. :ONS-US: Earnings Analysis: Q1, 2017 By the Numbers : March 16, 2017
    Capital Cube11 months ago

    Oncobiologics, Inc. :ONS-US: Earnings Analysis: Q1, 2017 By the Numbers : March 16, 2017

    Categories: Yahoo Finance Get free summary analysis Oncobiologics, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Oncobiologics, Inc. – Neurocrine Biosciences, Inc. and Momenta Pharmaceuticals, Inc. (NBIX-US and MNTA-US) that have also reported for this period. Highlights Summary numbers: Revenues of USD 0.30 million, Net ... Read more (Read more...)